These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2521060)

  • 21. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
    Georgotas A; McCue RE; Hapworth W; Friedman E; Kim OM; Welkowitz J; Chang I; Cooper TB
    Biol Psychiatry; 1986 Oct; 21(12):1155-66. PubMed ID: 3756264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-10-hydroxynortriptyline: effects and disposition of a potential novel antidepressant.
    Bertilsson L; Dahl-Puustinen ML; Nordin C
    Psychopharmacol Ser; 1989; 7():52-9. PubMed ID: 2687868
    [No Abstract]   [Full Text] [Related]  

  • 23. How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Chang I
    Arch Gen Psychiatry; 1988 Oct; 45(10):929-32. PubMed ID: 3421805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.
    Young RC; Mattis S; Alexopoulos GS; Meyers BS; Shindledecker RD; Dhar AK
    Psychopharmacol Bull; 1991; 27(3):291-4. PubMed ID: 1775601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C; Bertilsson L; Siwers B
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal analysis of nortriptyline side effects in elderly depressed patients.
    Miller MD; Pollock BG; Rifai AH; Paradis CF; Perel JM; George C; Stack JA; Reynolds CF
    J Geriatr Psychiatry Neurol; 1991; 4(4):226-30. PubMed ID: 1789911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline.
    Pollock BG; Mulsant BH; Nebes R; Kirshner MA; Begley AE; Mazumdar S; Reynolds CF
    Am J Psychiatry; 1998 Aug; 155(8):1110-2. PubMed ID: 9699704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of depressive symptoms to nortriptyline, phenelzine and placebo.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Br J Psychiatry; 1987 Jul; 151():102-6. PubMed ID: 3676606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Am J Psychiatry; 1987 Jun; 144(6):798-801. PubMed ID: 3592003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
    Bertilsson L; Otani K; Dahl ML; Nordin C; Aberg-Wistedt A
    Pharmacol Toxicol; 1991 Feb; 68(2):100-3. PubMed ID: 1852713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels and effects of nortriptyline in geriatric depressed patients.
    Kumar V; Smith RC; Reed K; Leelavathi DE
    Acta Psychiatr Scand; 1987 Jan; 75(1):20-8. PubMed ID: 3577837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.
    Georgotas A; Stokes P; McCue RE; Dubow A; Welkowitz J; Friedman E; Fanelli C; Chang I; Cooper TB
    J Affect Disord; 1986; 11(1):21-8. PubMed ID: 2944924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder.
    Geller B; Cooper TB; Graham DL; Fetner HH; Marsteller FA; Wells JM
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):34-44. PubMed ID: 1537779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
    Monteleone P; Fabrazzo M
    Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma 10-hydroxynortriptyline and renal function in elderly depressives.
    Young RC; Alexopoulos GS; Dhar AK; Kutt H
    Biol Psychiatry; 1987 Oct; 22(10):1283-7. PubMed ID: 3663780
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical predictors of response to antidepressants in elderly patients.
    Georgotas A; McCue RE; Cooper T; Chang I; Mir P; Welkowitz J
    Biol Psychiatry; 1987 Jun; 22(6):733-40. PubMed ID: 3297176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective reversible ketone formation from 10-hydroxylated nortriptyline metabolites in human liver.
    Breyer-Pfaff U; Nill K
    Xenobiotica; 1995 Dec; 25(12):1311-25. PubMed ID: 8719907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cardiovascular effects of bupropion and nortriptyline in depressed outpatients.
    Kiev A; Masco HL; Wenger TL; Johnston JA; Batey SR; Holloman LC
    Ann Clin Psychiatry; 1994 Jun; 6(2):107-15. PubMed ID: 7804386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
    Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
    Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.